Pasithea Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell KTTA and other ETFs, options, and stocks.

About KTTA

Pasithea Therapeutics Corp. is a biotechnology company focused on the research and discovery of new and treatments for psychiatric and neurological disorders. The company was founded by Yassine Bendiabdallah and Lawrence J. 

CEO
Tiago Reis Marques
CEOTiago Reis Marques
Employees
4
Employees4
Headquarters
Miami Beach, Florida
HeadquartersMiami Beach, Florida
Founded
2020
Founded2020
Employees
4
Employees4

KTTA Key Statistics

Market cap
4.46M
Market cap4.46M
Price-Earnings ratio
-0.13
Price-Earnings ratio-0.13
Dividend yield
Dividend yield
Average volume
208.01K
Average volume208.01K
High today
$1.76
High today$1.76
Low today
$1.64
Low today$1.64
Open price
$1.71
Open price$1.71
Volume
66.44K
Volume66.44K
52 Week high
$7.69
52 Week high$7.69
52 Week low
$0.9226
52 Week low$0.9226

People also own

Based on the portfolios of people who own KTTA. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.